Modulate Bio
Pre-clinicalOur platform enables us to develop novel, differentiated GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, anxiety and more
Founded
2021
Focus
Small Molecules
About
Our platform enables us to develop novel, differentiated GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, anxiety and more
Funding History
1SeedUndisclosedUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile